anti-Vascular Endothelial Growth Factor (VEGF) Antikörper

VEGF is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. Zusätzlich bieten wir Ihnen VEGF Kits (92) und VEGF Proteine (80) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
VEGF 7422 P15692
VEGF 22339 Q00731
VEGF 83785 P16612
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-VEGF Antikörper auf antikoerper-online.de

Showing 10 out of 218 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Lieferzeit Preis Details
Human Kaninchen Unkonjugiert FACS, IF (p), IHC (p), WB Antigen: 0.2 µg/100 µL  Primary: Antiserum, 1:500, 1:1000, 1:2000, 1:4000, 1:8000, 1:16000, 1:32000;  Secondary: HRP conjugated Goat-Anti-Rabbit IgG at 1: 5000;  TMB staining;  Read the data in MicroplateReader by 450 Formalin-fixed and paraffin embedded: human ovary carcinoma labeled with Anti-VEGF Polyclonal Antibody, Unconjugated (ABIN727205) at 1:200, followed by conjugation to the secondary antibody and DAB staining 100 μL 3 bis 7 Tage
$329.45
Details
Human Kaninchen Unkonjugiert ELISA, IHC, WB Western blot analysis of VEGF expression in rat spleen tissue sample. Western blot analysis of VEGF expression in A431 cells,The lane on the left is treated with the antigen-specific peptide. 100 μL 11 bis 12 Tage
$390.77
Details
Human Maus Unkonjugiert IF, IHC, WB Immunohistochemical staining of paraffin-embedded breast tissue using anti-VEGF mouse monoclonal antibody. (ABIN2452403, Dilution 1:50) Immunohistochemical staining of paraffin-embedded Adenocarcinoma of breast tissue using anti-VEGF mouse monoclonal antibody. (ABIN2452403, Dilution 1:50) 0.1 mL 2 bis 3 Tage
$462.00
Details
Hund Maus Unkonjugiert IHC, WB VEGF antibody (4G3) at 1:5000 dilution + Recombinant human VEGF165 0.1 mL 2 bis 3 Tage
$482.90
Details
Human Kaninchen HRP ELISA, WB Western Blot showing detection of Recombinant Human VEGF-165. 50ng of protein (Lane 1) was run on a 4-20% gel and transferred to 0.45 µm nitrocellulose. After blocking with 1% BSA-TTBS , diluted to 1X) 30 min at 20°C, Anti-VEGF-165 (RABBIT) Antibody Peroxidase Conjugate  secondary antibody was used at 1:1000 in Blocking Buffer for Fluorescent Western Blotting  and imaged using the Bio-Rad 4000 MP. Arrow indicates correct 19 kDa molecular weight position expected for rH-VEGF-165. 100 μg 5 bis 7 Tage
$598.50
Details
Human Kaninchen Biotin ELISA, WB Western Blot of Rabbit anti-VEGF-165 Antibody Biotin Conjugated. Lane 1: VEGF-165 Recombinant Protein. Load: 50 ng per lane. Primary antibody: Rabbit anti-VEGF-165 Antibody Biotin Conjugated at 1:1,000 overnight at 4°C. Secondary antibody: HRP Streptavidin (S000-03) at 1:40,000 for 30 min at RT. Block: ABIN925618 for 30 min at RT. Predicted/Observed size: 22 kDa, 22 kDa for VEGF-165 Isoform. 100 μg 5 bis 7 Tage
$598.50
Details
Rind (Kuh) Kaninchen Unkonjugiert ELISA, WB Western blot using  Protein-A Purified anti-bovine VEGF-A antibody shows detection of recombinant bovine VEGF-A at 17-19.2 kDa (arrowhead). Approximately 2 µg of recombinant protein was loaded per lane onto a 4-20% gradient gel followed by transfer to PVDF membrane. The membrane was blocked using 3% BSA  diluted 1:10. The primary antibody was used at a 1:333 dilution and was incubated with the blot for 2h at room temperature. The membrane was washed and reacted with a 1:10,000 dilution of800 Conjugated Affinity Purified Goat-anti-Rabbit IgG [H&L] MX10. Molecular weight estimation was made by comparison to prestained MW markers. Other detection systems will yield similar results. 100 μg 5 bis 7 Tage
$598.50
Details
Human Kaninchen Unkonjugiert IHC (p), WB IHC-P Image VEGF antibody detects VEGF protein at cytoplasm in mouse kidney by immunohistochemical analysis. Sample: Paraffin-embedded mouse kidney. VEGF antibody , diluted at 1:500. IHC-P Image VEGF antibody detects VEGF protein at cytoplasm in mouse muscle by immunohistochemical analysis. Sample: Paraffin-embedded mouse muscle. VEGF antibody , diluted at 1:500. 100 μL 3 bis 4 Tage
$466.18
Details
Human Kaninchen Unkonjugiert ELISA, WB Anti-human VEGF-121 by western blot shows detection of recombinant Human VEGF-121 raised in E.coli. Recombinant (0.1 µg, 28.4 kDa) protein was loaded onto and resolved by SDS-PAGE, then transferred to nitrocellulose. The membrane was blocked with 1% BSA in TBST for 30 min at RT, followed by incubation with , Inc. Anti-Human VEGF-121. After washing, membrane was probed with secondary antibody 649 Conjugated Anti-Rabbit IgG (H&L) (Goat) Antibody  diluted 1:20,000 in blocking buffer  for 30 min. at RT. Data was collected using Bio-Rad 4000 MP imaging system. 100 μg 5 bis 7 Tage
$598.50
Details
Human Kaninchen Unkonjugiert IHC, Neut, WB Western blot analysis with recombinant His-Tagged VEGF protein.Lane 1: 10 ng rh-VEGF Lane 2: 50 ng rh-VEGF Lane 3: 250 ng rh-VEGF Lane 4: 1 ug rh-VEGF 100 μg 2 bis 3 Tage
$245.00
Details

Am meisten referenzierte anti-VEGF Antikörper

  1. Dog (Canine) Monoclonal VEGF Primary Antibody für CyTOF, ELISA - ABIN152088 : Giatromanolaki, Koukourakis, Sivridis, Turley, Wykoff, Gatter, Harris: DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. in The Journal of pathology 2003 (PubMed)
    Show all 40 Pubmed References

  2. Cow (Bovine) Monoclonal VEGF Primary Antibody für ICC, IF - ABIN152071 : Zhang, Scott, Turley, Leek, Lewis, Gatter, Harris, Mackenzie, Rees, Bicknell: Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. in The Journal of pathology 1998 (PubMed)
    Show all 15 Pubmed References

  3. Human Polyclonal VEGF Primary Antibody für FACS, IF (p) - ABIN727205 : Zeng, Li, Dong, Ma, Jiang, Jin, Tu: Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis. in European journal of pharmacology 2013 (PubMed)
    Show all 7 Pubmed References

  4. Human Polyclonal VEGF Primary Antibody für ELISA, IHC - ABIN6265963 : Ai, Liu, Lu, Liang, Sun, Chen, Sun, Li, Liu, Zhang, Liu, Xiao, Jing, Sun, Zhou, Yang: Phenytoin silver: a new nanocompound for promoting dermal wound healing via comprehensive pharmacological action. in Theranostics 2017 (PubMed)
    Show all 6 Pubmed References

  5. Human Monoclonal VEGF Primary Antibody für IHC (f), IF - ABIN2689962 : Norrby-Teglund, Norgren, Holm, Andersson, Andersson: Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. in Infection and immunity 1994 (PubMed)
    Show all 4 Pubmed References

  6. Human Polyclonal VEGF Primary Antibody für ELISA, WB - ABIN1043812 : Rigopoulos, Tsiambas, Lazaris, Kavantzas, Papazachariou, Kravvaritis, Tsounis, Koliopoulou, Athanasiou, Karameris, Manaios, Sergentanis, Patsouris: Deregulation of EGFR/VEGF/HIF-1a signaling pathway in colon adenocarcinoma based on tissue microarrays analysis. in Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2010 (PubMed)
    Show all 3 Pubmed References

  7. Chicken Polyclonal VEGF Primary Antibody für ELISA, WB - ABIN250772 : Su, Rao, Guo, Li, Ahmed, Ni, Grossmann, Zhao: In ovo leptin administration inhibits chorioallantoic membrane angiogenesis in female chicken embryos through the STAT3-mediated vascular endothelial growth factor (VEGF) pathway. in Domestic animal endocrinology 2012 (PubMed)
    Show all 3 Pubmed References

  8. Human Monoclonal VEGF Primary Antibody für ICC, IF - ABIN153435 : Harasawa, Yasuda, Hirasawa, Miyazawa, Shida, Muramatsu, Douguchi, Matsui, Takekoshi, Kajiwara, Yoshiyuki Osamura, Mikami: Analysis of mTOR inhibition-involved pathway in ovarian clear cell adenocarcinoma. in Acta histochemica et cytochemica 2011 (PubMed)
    Show all 2 Pubmed References

  9. Mouse (Murine) Polyclonal VEGF Primary Antibody für Func, IF - ABIN2477085 : Leminen, Paavonen, Vesterinen, Wahlström, Rantala, Lehtinen: Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. in American journal of clinical pathology 1991 (PubMed)
    Show all 3 Pubmed References

  10. Mouse (Murine) Polyclonal VEGF Primary Antibody für ELISA, WB - ABIN2477086 : Nahrendorf, Swirski, Aikawa, Stangenberg, Wurdinger, Figueiredo, Libby, Weissleder, Pittet: The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. in The Journal of experimental medicine 2007 (PubMed)
    Show all 3 Pubmed References

Weitere Antikörper gegen VEGF Interaktionspartner

Human Vascular Endothelial Growth Factor (VEGF) Interaktionspartner

  1. VEGF, CD34, and CD44 immunohistochemical expression was evaluated in the interproximal biopsies of marginal peri-implant tissue and correlated with the clinical parameters. Peri-implantitis patients had significantly higher levels of VEGF, CD34, and CD44 expression compared to the other groups. for peri-implantitis

  2. Promote airway hyperresponsiveness through production of VEGFA

  3. Down-regulation of HIF-1alpha can inhibit the proliferation, migration, and invasion of gastric cancer possibly by inhibiting PI3K/AKT pathway and VEGF expression

  4. ShRNA targeting HIF-1alpha can effectively silence the expression of HIF-1alpha, reduce the expression of VEGF and up-regulate the expression of PEDF in human corneal epithelial cells

  5. High VEGFA expression is associated with acute myeloid leukemia.

  6. In vitro mechanism study revealed that the advanced glycation end products (AGEs) significantly increased the expression of Cyr61 in retinal pigment epithelial (RPE) cells, mimicking the effects of diabetes. In turn, the increased Cyr61 enhanced VEGF expression through FAK and PI3K/Akt pathways.

  7. Results show that the expression levels of vascular endothelial growth factor A (VEGFA), angiopoietin-2 (ANGPT2), and tissue plasminogen activator (PLAT) were suppressed in ADAM9-silenced cells, which in turn leads to decreases in angiogenesis, vascular remodeling, and tumor growth in vivo.

  8. Followed by an increase in hypoxia-inducible factor-1alpha (HIF-1alpha) protein and VEGF mRNA expression.

  9. The inhibition of FLT1 ectodomain cleavage by VEGF-A is dependent neither on receptor activation nor on internalization.

  10. LINGO1 might be a positive primary glioblastoma prognostic gene and C7orf31 and VEGFA might be negative prognosticators.

  11. Fluorescent VEGF-A isoforms have been evaluated for their ability to discriminate between VEGFR2 and NRP1 in real-time ligand binding studies in live cells. VEGF165a, VEGF121a, and VEGF165b were single-site labeled with tetramethylrhodamine (TMR). VEGFR2 and NRP1 have markedly distinct kinetic profiles binding VEGF165a-TMR.

  12. Polymorphisms of the VEGF gene rs699947 locus may contribute to an increased risk for colonic Crohn's disease (CD) among Chinese patients, but may play a protective role in patients with ileal lesion. Individuals carrying the TT genotype for VEGF rs3025039 locus may be less susceptible to non-stricturing and non-penetrating CD.

  13. VEGF165b cannot be treated as a prognostic factor. VEGF receptors correlated with selected clinicopathological data of malignant tumors, indicating their possible role as a prognostic marker. The balance of VEGF isoforms have a limited influence on the development of parotid glands tumors.

  14. VEGFA played an important role in hypoxia-induced vasculogenic mimicry through regulating epithelial-mesenchymal transition and stemness, which may eventually fuel the migration and invasion of salivary adenoid cystic carcinoma.

  15. Results show that individual polymorphisms of VEGF do not appear to contribute to prostate cancer. However, a combination of risky alleles of the studied polymorphisms significantly increases the risk of prostate cancer in Slovak patients.

  16. revascularization and progression of pancreatic neuroendocrine tumors (PNETs) under extended vascular-endothelial growth factor A (VEGFA) blockade are dependent on periostin (POSTN), a matricellular protein expressed by stromal cells.

  17. Metastatic breast cancer patients with elevated levels of sVEGF have significantly worse clinical outcome. This finding supports the biological role of VEGF in breast cancer.

  18. The results of the present investigation, VEGF serum levels are elevated in association with cognitive impairment in AD patients; show a significant severity-related increase in ApoE4 carriers.

  19. HIF1A and VEGF could regulate each other in peritoneal mesothelial cell in the mediation of miR-17-5p and 3'UTR, indicating HIF1A and VEGF might regulate each other through competing endogenous RNA mechanism in the development of peritoneal fibrosis.

  20. Report association between VEGF and Clusterin up-regulation and neurological symptoms of patients with high-grade carotid artery stenosis.

Mouse (Murine) Vascular Endothelial Growth Factor (VEGF) Interaktionspartner

  1. findings demonstrate that COX-2 activity is important in the recruitment of VEGF-secreting Ly6C(high) monocytes, which are involved in VILI pathogenesis, and indicate that the suppression of COX-2 activity might be a useful strategy in mitigating ventilator-induced lung injury.

  2. these are the first studies to assess and compare "off-target" host secretory effects of VEGF and PD-1 pathway inhibition that occur independent of tumor stage or tumor response to therapy.

  3. The present study found that increased choroidal neovascularisation severity together with higher expression of Cyr61 and VEGF in diabetes mice compared with control mice.

  4. In this study, we investigated the proliferation, migration, and growth factor expression of human dermal papilla (DP) cells in the presence or absence of treatment with mesenchymal stem cell extracellular vesicles (MSC-EVs)..DP cells treated with MSC-EVs displayed increased expression and secretion of VEGF and IGF-1.

  5. Herein, we reported a novel dual-targeting therapy for glioblastoma through simultaneous blockade of VEGF and CD47 signaling.

  6. Conditional knock-down of Vegf attenuates induced osteoarthritis.

  7. revascularization and progression of pancreatic neuroendocrine tumors (PNETs) under extended vascular-endothelial growth factor A (VEGFA) blockade are dependent on periostin (POSTN), a matricellular protein expressed by stromal cells.

  8. Study showed that administering vascular endothelial growth factor concurrently increased the expression of disintegrin and metalloproteinase domain-containing protein 10 and decreased the expression of beta-site APP cleaving enzyme 1, which contributes to the enhanced clearance of amyloid-beta in vivo.

  9. These results suggest that retinoic acids produced by Aldh1a1 in the neural retina directs dorsal choroidal vascular development via Sox9 upregulation in the dorsal retinal pigment epithelial cells to enhance retinal pigment epithelial-derived VEGF secretion.

  10. FENDRR could promote the apoptosis of FENDRR could promote the apoptosis of human brain microvascular endothelial cells via miR-126 regulating VEGFA in hypertensive intracerebral hemorrhage via miR-126 regulating VEGFA in hypertensive intracerebral hemorrhage

  11. Letter: PlGF in promotes skin angiogenesis independently of VEGF-A.

  12. Infection with enterotoxins-producing Clostridium difficile strains but not with a TcdA(-)TcdB(-) isogenic mutant increases colonic vascular permeability in mice and elevates vascular endothelial growth factor A (VEGF-A). Both neutralization of VEGF-A and inhibition of its signalling pathway attenuated Clostridium difficile infection pathogenesis in vivo.

  13. When miR27a expression was depleted by miR27a inhibitor, the protective effect of betaelemene on RNV was eliminated. The present study demonstrated that belemene reduced RNV in mouse oxygen-induced retinopathy (OIR) models via miR27a upregulation, leading to reduced VEGF expression.

  14. the results of immunofluorescence staining of hepatic myeloid cells and detection of vascular growth factor A (VEGFA) in blood and liver suggested that the reduced degeneration of collagen in liver sinusoids was associated with decreased myeloid cell adhesion and the downregulation of VEGFA in the liver.

  15. repressed Dll4-Notch1 signaling pathway but not downregulation of VEGF-A expression are responsible for hyperoxia induced pervasive vessel regression.

  16. Here the authors have demonstrated that TGF-beta/Smad signaling plays an important role in Laser-induced choroidal neovascularization formation through down-regulation of VEGF and TNF-alpha expressions.

  17. renal ischemia/reperfusion (I/R) induced miR-377 expression, which upregulated VEGF expression to attenuate renal I/R-induced oxidative stress and inflammation, and finally ameliorated renal dysfunction.

  18. Mice exposed to treadmill exercise after cerebral ischemia showed a significant up-regulation in expression of VEGF compared to non-exercised animals.

  19. At this late stage, glomerular VEGF and fibrosis-related-gene expression was also significantly increased compared with nondiabetic db/m mice. These results suggest that LRG1 plays a pivotal role in the initial development of diabetic nephropathy by promoting abnormal angiogenesis, thereby suggesting that LRG1 is a potential preemptive therapeutic target of diabetic nephropathy.

  20. uterine endothelial cells promoted miR138 to induce exosomemediated inflammation and apoptosis in Ems through the VEGF/NFkappaB signaling pathway.

Cow (Bovine) Vascular Endothelial Growth Factor (VEGF) Interaktionspartner

  1. data for the first time demonstrate a calpain/PTP1B/VEGFR2 negative feedback loop in the regulation of VEGF-induced angiogenesis. Modulation of local PTP1B and/or calpain activities may prove beneficial in the treatment of impaired wound healing in diabetes.

  2. Studied the effect of cyclic uniaxial stretch (20%, 1 Hz), with and without the stimulation of vascular endothelial growth factor (VEGF), on sprouting angiogenesis by employing a stretchable three-dimensional cell culture model.

  3. Study shows that VEGFA mRNA in mammalian endothelial cells undergoes programmed translational readthrough (PTR) generating VEGF-Ax, an isoform containing a unique 22-amino-acid C terminus extension.

  4. Data indicate that superoxide dismutase (SOD) inhibited high glucose (HG)-induced expression of uPAR and VEGF in bovine retinal microvascular endothelial cell (REC).

  5. Exposure of endothelial cells to VEGF, high glucose, or hydrogen peroxide up-regulated the XBP1/IRE1 alpha and ATF6 arms of the unfolded protein response compared with untreated cells.

  6. Microvascular endothelial cells are more susceptible than aortic cells to advanced glycation end products-enhanced permeability and that AGE-enhanced permeability is dependent on VEGF expression induced by reactive oxygen species.

  7. VEGF supports germ cell survival and sperm production in bulls.

  8. analysis of polymorphisms of bovine VEGF gene and their associations with growth traits in Chinese cattle

  9. VEGF mRNA expression at estrus was higher than at the early I, early II and late luteal stages (P<0.05), whereas VEGF protein content was greatest at the early I luteal stage and decreased thereafter

  10. Alterations in the expression of VEGF-A and bFGF systems suggest that angiogenic factors are involved in abnormal placental development in cloned gestations, contributing to impaired fetal development and poor survival rates.

  11. Advanced glycation end products increase, through a protein kinase C-dependent pathway, expression in reignal endothelial cells; inhibited by gliclazide.

  12. VEGF signaling is regulated by atrial natriuretic peptide, which preserves endothelial cell tight junction functional morphology

  13. Airline pilots are good candidates to see if mutation in the VEGF promoter are responsible for some cases of amyotrophic lateral sclerosis.

  14. role in dowregulating Flk-1/KDR involves Cbl-mediated ubiquitination

  15. interaction with glucose-6-phosphate dehydrogenase is involved in angiogenesis

  16. Results suggest that leptin might elicit angiogenesis through vascular endothelial growth factor induction as well as pigment epithelium-derived factor suppression in pericytes.

  17. Shear stress and VEGF converge at the membrane receptor Flk-1 and these stimuli share the Flk-1/Cbl/Akt pathway in activating IKK activation.

  18. Tumor cells activate confluent, quiescent EC, promoting survival, phenotypic, and gene expression changes. Of importance, VEGF antagonism converts tumor-conditioned medium from protective to endothelial cell-damaging effects.

  19. MGP plays a role in endothelial cell function, by increasing transforming growth factor-beta1 activity and stimulating VEGF expression

  20. placenta growth factor expression is regulated by both VEGF and hyperglycaemia via VEGFR-2

Xenopus laevis Vascular Endothelial Growth Factor (VEGF) Interaktionspartner

  1. Etv6, positively regulates vegfa expression during Xenopus blood stem cell development through multiple transcriptional inputs. In agreement with its established repressive functions, Etv6 directly inhibits expression of the repressor foxo3, to prevent Foxo3 from binding to and repressing the vegfa promoter.

  2. VEGFA produced in the somites is required to initiate adult haemangioblast programming in the adjacent dorsal lateral plate mesoderm.

  3. sequential, isoform-specific VEGFA signaling successively induces the endothelial, arterial, and hematopoietic stem cell programs in the dorsal aorta.

  4. VEGF induces stromal cell migration or recruitment that are required for blood vessel formation.

  5. Functional roles of VEGF122 and VEGF170 during development were examined.

  6. increased VEGF(170) levels disturb Hand-1 expression in the region required for normal heart morphogenesis

Guinea Pig Vascular Endothelial Growth Factor (VEGF) Interaktionspartner

  1. After acoustic trauma, vascular endothelial growth factor was up-regulated both in the cochlea and vestibule. Expression in both structures suggests a reparative role with potentially therapeutic implications.

  2. Studied the role of T help 17 cells (Th17) and STAT3-VEGF pathway in pathogenesis of psoriasis.

VEGF Antigen-Profil

Protein Überblick

This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms.

Genbezeichner und Symbole assoziert mit VEGF

  • vascular endothelial growth factor A (VEGFA) Antikörper
  • vascular endothelial growth factor A (Vegfa) Antikörper
  • vascular endothelial growth factor A L homeolog (vegfa.L) Antikörper
  • vascular endothelial growth factor (VEGF) Antikörper
  • vascular endothelial growth factor precursor (vegf) Antikörper
  • eVEGF120 Antikörper
  • eVEGF164 Antikörper
  • MVCD1 Antikörper
  • vegf Antikörper
  • vegf-a Antikörper
  • Vegf120 Antikörper
  • VEGF164 Antikörper
  • Vegf188 Antikörper
  • Vpf Antikörper

Bezeichner auf Proteinebene für VEGF

vascular permeability factor , vascular endothelial growth factor 164 , vascular endothelial growth factor A-a , VEGF-A , VPF , vascular endothelial growth factor 188 , vascular endothelial growth factor , vascular endothelial growth factor precursor

GENE ID SPEZIES
7422 Homo sapiens
22339 Mus musculus
83785 Rattus norvegicus
281572 Bos taurus
373589 Xenopus laevis
395909 Gallus gallus
403802 Canis lupus familiaris
100329011 Saccoglossus kowalevskii
100136118 Oncorhynchus mykiss
100713483 Cavia porcellus
Ausgewählte Anbieter für anti-VEGF (VEGF) Antikörper
Haben Sie etwas anderes gesucht?